ArticleERJ open research2020

Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data.

Godsfavour Umoru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.